FDA
-
-
-
-
-
-
-
Constellation Pharmaceuticals Presents Phase 1 Data for CPI-0209 at ASCO Annual Meeting
-
-
-
-
-
-
-
Constellation Pharmaceuticals Announces Fourth-Quarter and Full-Year 2020 Financial Results
-
-
-
-
-
-
-
Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update
-
-
-
-
-
-
-
Constellation Pharmaceuticals Provides Update of Preliminary Data for CPI-0610 in Three EHA Abstracts
-
-
-
-
-
-
-
Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2019 Financial Results
-
-
-
-
-
-
-
Constellation Pharmaceuticals Advances CPI-0209 into Clinical Trials, Expanding its EZH2 Franchise
-
-
-
-
-
-
-
Constellation Pharmaceuticals Presents Poster on Studies of CPI-0209 in Bladder Cancer at AACR Meeting
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

